Tara Dubois
Head of Human Resource Amyloidosis Business Alnylam Pharmaceuticals
Tara DuBois is Head of HR, U.S. Amyloidosis Business at Alnylam Pharmaceuticals, with 15+ years of senior HR leadership across Moderna and Procter & Gamble, specialising in organisation transformation, talent strategy, and AI enabled ways of working.
Seminars
AI is moving from pilot to practice across life sciences HR teams, but the gap between early experiments and enterprise-wide, responsible adoption remains wide. This panel brings together HR and people leaders who are actively deploying AI across recruiting, learning, workforce planning, and analytics to share what is working, what the guardrails look like in practice, and where the real ROI is emerging. Expect candid, experience-led perspectives, not theory.
- Where AI is delivering the most tangible value in HR right now, and where the hype still exceeds the reality
- How organizations are building the guardrails, ethics frameworks, and accountability mechanisms that make AI use responsible
- What it takes to move from isolated pilots to enterprise-wide AI adoption across the people function
- How to communicate AI strategy to employees in a way that builds trust rather than fear
- How can life sciences organizations rethink hiring when roles are evolving faster than job descriptions due to new markets, competition, and shifting go‑to‑market strategies?
- Explore how Alnylam adapted its hiring approach during a major US sales expansion by prioritizing adaptability, learning agility, and coachability over traditional experience‑led selection for newly created and fluid roles
- Learn how this shift supported the build‑out of two distinct sales forces and a planned 30–40% expansion of the US sales organization within a single year, while acknowledging the ongoing uncertainty and evolution of role design
This interactive Q&A examines what it takes for TA to operate as a genuine growth partner, whether that means flexing to support a commercial scale-up, or transforming operating practices to match a new strategic direction. Drawing on both the hypergrowth partnership model and the enterprise transformation approach explored in the Discover sessions, participants will examine the conditions and design choices that enable TA to deliver at pace without sacrificing quality.
- What partnership structures between TA and HRBPs most reliably deliver the speed and alignment needed during hypergrowth?
- How do you transform TA operating practices while continuing to deliver at the pace the business demands?
- What does TA capacity planning look like when growth is rapid and the commercial build timeline is compressed?
- How do you build TA credibility with business leaders in an organization that has historically seen TA as transactional?
